-
1 Comment
Teladoc Health, Inc is currently in a long term uptrend where the price is trading 46.5% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the sector with a price to sales ratio of 0.0.
Finally, its free cash flow grew by 138.7% to $32M since the same quarter in the previous year.
Based on the above factors, Teladoc Health, Inc gets an overall score of 3/5.
ISIN | None |
---|---|
Exchange | LSE |
CurrencyCode | USD |
Sector | |
Industry |
Market Cap | 2B |
---|---|
PE Ratio | None |
Dividend Yield | 0.0% |
Beta | 1.1 |
Target Price | None |
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0LDR.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025